House of Lords hears evidence on life sciences and Brexit

17-10-2017

The House of Lords is hearing from companies and regulators today on issues including the government’s life sciences strategy and Brexit’s impact on the industry.


House of Lords; life sciences; Brexit; life sciences strategy; life sciences investment; Professor Sir John Bell

LSIPR